Research Article

Advancements in DNA Origami Nanorobots for Targeted Intracellular Delivery of Chemotherapeutic Agents in Chemoresistant Cancer Cells

118 reads
JO MO Bio Ino, 2026, 1 (1), 45-52, ISSN

Abstract

Multidrug resistance (MDR) remains one of the most formidable obstacles in modern oncological pharmacotherapy, frequently mediated by the overexpression of ATP-binding cassette (ABC) transmembrane efflux transporters such as P-glycoprotein. To circumvent active efflux mechanisms and mitigate off-target systemic toxicity, structural DNA nanotechnology offers unprecedented architectural control for nanoscale biomedical robotics. In this study, we report the design, self-assembly, and functional validation of an autonomous, aptamer-gated DNA origami nanorobot engineered for the precise intracellular delivery of doxorubicin into chemoresistant breast adenocarcinoma cells (MCF-7/ADR). The tubular nanorobot is fabricated using scaffolded DNA origami and held in a closed configuration via duplexed lock strands incorporating the nucleolin-specific AS1411 aptamer. Upon encountering cell-surface nucleolin, conformational reconfiguration triggers autonomous opening, exposing intercalated doxorubicin specifically within the target microenvironment. Transmission electron microscopy and atomic force microscopy confirmed the high-fidelity assembly and ligand-responsive mechanical actuation of the nanorobots. In vitro assays demonstrated robust cellular internalization via endocytosis, bypassing membrane-bound efflux pumps and facilitating lysosomal escape. The nanorobots exhibited a 7.4-fold decrease in the half-maximal inhibitory concentration (IC50) compared to free doxorubicin in MCF-7/ADR cells, while maintaining negligible cytotoxicity toward non-malignant control lines. These findings illustrate the efficacy of smart, reconfigurable DNA nanorobots as versatile therapeutic vectors capable of reversing cancer chemoresistance through targeted supramolecular delivery.

Keywords p-glycoprotein dna origami chemoresistance Nanorobots Targeted intracellular delivery
Authors 2

The team behind this paper

2 authors, 2 institutions.

This paper Innovation Research Institute — Japan Innovation Research Ins… 1 author University of Cape Town — South Africa University of Cape Town 1 author Dr. Kenjiro Takahashi — corresponding author KT Dr. Kenjiro Takahashi ✉ Prof. Amara Okafor AO Prof. Amara Okafor

Readership

118 reads over 4 months.

#6 most read in this journal this month
August 2026 November 2026

Bibliographic Information

Dr. Kenjiro Takahashi, Prof. Amara Okafor, (2026). Advancements in DNA Origami Nanorobots for Targeted Intracellular Delivery of Chemotherapeutic Agents in Chemoresistant Cancer Cells, SciMatic Journal of Molecular Bio-Innovations, 1(1): 45-52
Bibtex Citation
@article{dr._kenjiro_takahashi2026jmbi,
author = {Dr. Kenjiro Takahashi and Prof. Amara Okafor},
title = {Advancements in DNA Origami Nanorobots for Targeted Intracellular Delivery of Chemotherapeutic Agents in Chemoresistant Cancer Cells},
journal = {SciMatic Journal of Molecular Bio-Innovations},
year = {2026},
volume = {1},
number = {1},
pages = {45-52},
doi = {},
url = {https://scimatic.org/show_manuscript/9406}
}
APA Citation
Takahashi, D.K., Okafor, P.A., (2026). Advancements in DNA Origami Nanorobots for Targeted Intracellular Delivery of Chemotherapeutic Agents in Chemoresistant Cancer Cells. SciMatic Journal of Molecular Bio-Innovations, 1(1), 45-52. https://doi.org/

Author Information

  • To change your profile photo, login to scimatic.org, go to your profile and change the photo.
  • Any photo that shows your face will do: we crop it to your head and shoulders and give it a plain background automatically.
  • To sign in, go to Sign in and enter the e-mail address registered with the article: we e-mail you a one-time sign-in link (there is no password).
  • In case of any other problem, contact your editor directly or write to us at info @ scimatic.org